March 7, 2017 / 2:32 PM / 5 months ago

BRIEF-U.S. FDA approves Spectral's third PMA module for its toraymyxin treatment of endotoxemic septic shock

March 7 (Reuters) - Spectral Medical Inc

* U.S. FDA approves Spectral's third PMA module for its toraymyxin treatment of endotoxemic septic shock

* Spectral Medical Inc - "plan to file our fourth and final module containing clinical data early in Q2 of this year" Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below